UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 164

Sortiert nach

Immunity, atherosclerosis and cardiovascular disease

BMC medicine, 2013-05, Vol.11 (1), p.117-117, Article 117

Frostegard, Johan

2013

Link zum Volltext

Verfügbarkeit prüfen

Systemic lupus erythematosus and cardiovascular disease

Journal of internal medicine, 2023-01, Vol.293 (1), p.48-62

Frostegard, J

2023

Link zum Volltext

Verfügbarkeit prüfen

Antibodies against Oxidation-Specific Epitopes and Risk of Acute Myocardial Infarction

Journal of lipid research, 2023-08, Vol.64 (8), p.100412-100412, Article 100412

Frostegård, Johan

2023

Link zum Volltext

Verfügbarkeit prüfen

The role of PCSK9 in inflammation, immunity, and autoimmune diseases

Expert review of clinical immunology, 2022, Vol.18 (1), p.67-74

Frostegård, Johan

2022

Link zum Volltext

Verfügbarkeit prüfen

Atherosclerosis in patients with autoimmune disorders

Arteriosclerosis, thrombosis, and vascular biology, 2005-09, Vol.25 (9), p.1776

Frostegård, Johan

2005

Link zum Volltext

Verfügbarkeit prüfen

Antibodies against Phosphorylcholine-Implications for Chronic Inflammatory Diseases

Metabolites, 2023-06, Vol.13 (6), p.720

Frostegard, J

2023

Link zum Volltext

Verfügbarkeit prüfen

Antibodies against phosphorylcholine and protection against atherosclerosis, cardiovascular disease and chronic inflammation

Expert review of clinical immunology, 2022-05, Vol.18 (5), p.525-532

Frostegård, Johan

2022

Link zum Volltext

Verfügbarkeit prüfen

Potential natural immunization against atherosclerosis in hibernating bears

Scientific reports, 2021-06, Vol.11 (1), p.12120-12120, Article 12120

2021

Link zum Volltext

Verfügbarkeit prüfen

Low levels of PCSK9 are associated with remission in patients with rheumatoid arthritis treated with anti-TNF-α: potential underlying mechanisms

Arthritis research & therapy, 2021, Vol.23 (1), p.32-9, Article 32

2021

Link zum Volltext

Verfügbarkeit prüfen

Proprotein convertase subtilisin kexin 9 is associated with disease activity and is implicated in immune activation in systemic lupus erythematosus

Lupus, 2020-07, Vol.29 (8), p.825-835

2020

Link zum Volltext

Verfügbarkeit prüfen

Antibodies against phosphorylcholine in hospitalized versus non-hospitalized obese subjects

Scientific reports, 2021-10, Vol.11 (1), p.20246-20246, Article 20246

2021

Link zum Volltext

Verfügbarkeit prüfen

Low level natural antibodies against phosphorylcholine: A novel risk marker and potential mechanism in atherosclerosis and cardiovascular disease

Clinical immunology (Orlando, Fla.), 2010-01, Vol.134 (1), p.47-54

Frostegard, J

2010

Link zum Volltext

Verfügbarkeit prüfen

Antibodies against malondialdehyde among 60-year-olds: prediction of cardiovascular disease

Scientific reports, 2023-09, Vol.13 (1), p.15011-15011, Article 15011

2023

Link zum Volltext

Verfügbarkeit prüfen

IgM antibodies against malondialdehyde and phosphorylcholine are together strong protection markers for atherosclerosis in systemic lupus erythematosus: Regulation and underlying mechanisms

Clinical immunology (Orlando, Fla.), 2016-05, Vol.166-167, p.27-37

2016

Link zum Volltext

Verfügbarkeit prüfen

Oxidized Low‐Density Lipoprotein (OxLDL)–Treated Dendritic Cells Promote Activation of T Cells in Human Atherosclerotic Plaque and Blood, Which Is Repressed by Statins: microRNA let‐7c Is Integral to the Effect

Journal of the American Heart Association, 2016-09, Vol.5 (9), p.n/a

2016

Link zum Volltext

Verfügbarkeit prüfen

Risk factors for cardiovascular disease in systemic lupus erythematosus

Circulation (New York, N.Y.), 2001-10, Vol.104 (16), p.1887-1893

2001

Link zum Volltext

Verfügbarkeit prüfen

IgM antibodies to oxidized phosphatidylserine as protection markers in cardiovascular disease among 60-year olds

PloS one, 2017-04, Vol.12 (4), p.e0171195-e0171195

2017

Link zum Volltext

Verfügbarkeit prüfen

Patients with SLE have higher risk of cardiovascular events and mortality in comparison with controls with the same levels of traditional risk factors and intima-media measures, which is related to accumulated disease damage and antiphospholipid syndrome: a case–control study over 10 years

Lupus science & medicine, 2021-02, Vol.8 (1), p.e000454

2021

Link zum Volltext

Verfügbarkeit prüfen

Induction of dendritic cell-mediated T-cell activation by modified but not native low-density lipoprotein in humans and inhibition by annexin a5: involvement of heat shock proteins

Arteriosclerosis, thrombosis, and vascular biology, 2015-01, Vol.35 (1), p.197

2015

Link zum Volltext

Verfügbarkeit prüfen

Higher levels of anti-phosphorylcholine autoantibodies in early rheumatoid arthritis indicate lower risk of incident cardiovascular events

Arthritis research & therapy, 2021-07, Vol.23 (1), p.1-201, Article 201

2021

Link zum Volltext

Verfügbarkeit prüfen

Carotid atherosclerosis, disease measures, oxidized low-density lipoproteins, and atheroprotective natural antibodies for cardiovascular disease in early rheumatoid arthritis -- an inception cohort study

Journal of rheumatology, 2012-06, Vol.39 (6), p.1146

2012

Link zum Volltext

Verfügbarkeit prüfen

Antibodies against native and oxidized cardiolipin and phosphatidylserine and phosphorylcholine in atherosclerosis development

PloS one, 2014-12, Vol.9 (12), p.e111764-e111764

2014

Link zum Volltext

Verfügbarkeit prüfen

Naturally occurring human phosphorylcholine antibodies are predominantly products of affinity-matured B cells in the adult

The Journal of immunology (1950), 2014-05, Vol.192 (10), p.4551-4559

2014

Link zum Volltext

Verfügbarkeit prüfen

Induction of Dendritic Cell–Mediated Activation of T Cells From Atherosclerotic Plaques by Human Heat Shock Protein 60

Journal of the American Heart Association, 2017-11, Vol.6 (11), p.n/a

2017

Link zum Volltext

Verfügbarkeit prüfen

Oxidized but not native cardiolipin has pro-inflammatory effects, which are inhibited by Annexin A5

Atherosclerosis, 2014-08, Vol.235 (2), p.592-598

2014

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 164

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(157)
Mit Volltextzugriff
(142)

Publikationsform

Artikel
(161)
Tagungsberichte
(3)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Immunity, atherosclerosis and cardiovascular disease

Systemic lupus erythematosus and cardiovascular disease

Antibodies against Oxidation-Specific Epitopes and Risk of Acute Myocardial Infarction

The role of PCSK9 in inflammation, immunity, and autoimmune diseases

Atherosclerosis in patients with autoimmune disorders

Antibodies against Phosphorylcholine-Implications for Chronic Inflammatory Diseases

Antibodies against phosphorylcholine and protection against atherosclerosis, cardiovascular disease and chronic inflammation

Potential natural immunization against atherosclerosis in hibernating bears

Low levels of PCSK9 are associated with remission in patients with rheumatoid arthritis treated with anti-TNF-α: potential underlying mechanisms

Proprotein convertase subtilisin kexin 9 is associated with disease activity and is implicated in immune activation in systemic lupus erythematosus

Antibodies against phosphorylcholine in hospitalized versus non-hospitalized obese subjects

Low level natural antibodies against phosphorylcholine: A novel risk marker and potential mechanism in atherosclerosis and cardiovascular disease

Antibodies against malondialdehyde among 60-year-olds: prediction of cardiovascular disease

IgM antibodies against malondialdehyde and phosphorylcholine are together strong protection markers for atherosclerosis in systemic lupus erythematosus: Regulation and underlying mechanisms

Oxidized Low‐Density Lipoprotein (OxLDL)–Treated Dendritic Cells Promote Activation of T Cells in Human Atherosclerotic Plaque and Blood, Which Is Repressed by Statins: microRNA let‐7c Is Integral to the Effect

Risk factors for cardiovascular disease in systemic lupus erythematosus

IgM antibodies to oxidized phosphatidylserine as protection markers in cardiovascular disease among 60-year olds

Patients with SLE have higher risk of cardiovascular events and mortality in comparison with controls with the same levels of traditional risk factors and intima-media measures, which is related to accumulated disease damage and antiphospholipid syndrome: a case–control study over 10 years

Induction of dendritic cell-mediated T-cell activation by modified but not native low-density lipoprotein in humans and inhibition by annexin a5: involvement of heat shock proteins

Higher levels of anti-phosphorylcholine autoantibodies in early rheumatoid arthritis indicate lower risk of incident cardiovascular events

Carotid atherosclerosis, disease measures, oxidized low-density lipoproteins, and atheroprotective natural antibodies for cardiovascular disease in early rheumatoid arthritis -- an inception cohort study

Antibodies against native and oxidized cardiolipin and phosphatidylserine and phosphorylcholine in atherosclerosis development

Naturally occurring human phosphorylcholine antibodies are predominantly products of affinity-matured B cells in the adult

Induction of Dendritic Cell–Mediated Activation of T Cells From Atherosclerotic Plaques by Human Heat Shock Protein 60

Oxidized but not native cardiolipin has pro-inflammatory effects, which are inhibited by Annexin A5

Suchergebnisse filtern